Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     

  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     

  • Bitcoin GBP

    50,576.05
    -836.61 (-1.63%)
     

  • CMC Crypto 200

    1,324.95
    -71.59 (-5.12%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

The Beauty Health Company (SKIN) Stock Jumps 5.6%: Will It Continue to Soar?

Zacks Equity Research
·2-min read

The Beauty Health Company SKIN shares ended the last trading session 5.6% higher at $14.61. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 0.9% gain over the past four weeks.

The Beauty Health Company scored a strong price rise on optimism surrounding the company’s expansion of partnership with Murad, a renowned clinical skincare brand, to launch the new Clarifying Booster for HydraFacial. The new booster has been formulated to particularly address breakouts and troublesome skin, as part of a customized HydraFacial experience. HydraFacial first teamed up with Murad in 2021, and currently offers the Murad Retinol Booster, the Murad Vita-C Booster and the new Clarifying Booster.

This company is expected to post quarterly earnings of $0.01 per share in its upcoming report, which represents a year-over-year change of -87.5%. Revenues are expected to be $86.06 million, up 29.4% from the year-ago quarter.

Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.

ADVERTISEMENT

For The Beauty Health Company, the consensus EPS estimate for the quarter has been revised 50% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on SKIN going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

The Beauty Health Company is a member of the Zacks Medical Services industry. One other stock in the same industry, Avantor, Inc. AVTR, finished the last trading session 1% higher at $31.60. AVTR has returned -1.5% over the past month.

Avantor, Inc.'s consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.38. Compared to the company's year-ago EPS, this represents a change of +8.6%. Avantor, Inc. currently boasts a Zacks Rank of #3 (Hold).


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
The Beauty Health Company (SKIN) : Free Stock Analysis Report
 
Avantor, Inc. (AVTR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research